BUZZ-因缺乏催化剂,派博桑德勒将 CONMED 的评级下调至 "中性"

路透中文
Mar 17
BUZZ-因缺乏催化剂,派博桑德勒将 CONMED 的评级下调至 "中性"

3月17日 - ** Piper Sandler 将医疗技术公司 CONMED CNMD.N 的评级从 "增持 "下调至 "中性",理由是缺乏近期催化剂

** 券商称,对AirSeal业绩和执行失误的持续担忧已拖累该股近两年时间

** 派珀桑德勒将PT值下调至39美元,与上次收盘价相比仍有4.3%的上涨空间

** 六家券商均将该股评级为 "持有";他们的预测中值为 43 美元--LSEG 数据

** 截至上次收盘,该股今年累计下跌约 7.9%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10